Latest Heparin Stories
BASKING RIDGE, N.J., Sept.
LAKE FOREST, Ill., Aug. 31 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S.
Data from a phase II trial of an investigational intravenous drug designed to block the formation of blood clots shows potential to reduce the risk of death, a second heart attack, or other coronary complications compared with the current standard of care in patients presenting with acute coronary syndromes (heart attacks or unstable angina).
BASKING RIDGE, N.J., Aug.
â€œThickâ€ blood can cause heart attack and stroke, but also prevent them. Scientists at Heidelberg University Hospital have explained the mechanism of this clinical paradox for the first time on an animal model.
BOZEN, Italy, August 17 /PRNewswire/ -- Health Robotics today announced that it has reached an agreement with Gregorio Maranon Foundation to sell and install its revolutionary i.v.STATION robot at the GMU Hospital this October, concurrent with the nine American i.v.STATION installations at Duke University, MD Anderson Cancer Center, Brigham & Women's, Univ.
BRIDGEWATER, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S.
OCEAN, N.J., Aug.
Continuing to help ensure the identity, purity and quality of heparin, the U.S. Pharmacopeial (USP) Convention has revised written and physical standards for the widely used blood thinner.
Scientists in New York and North Carolina are reporting assembly of the first functioning prototype of an artificial Golgi organelle. That key structure inside cells helps process and package hormones, enzymes, and other substances that allow the body to function normally.
- A trick or prank.